Abstract
The autonomic nervous system (ANS) plays a key role in the maintenance of cardiovascular homeostasis. The main transmitters involved are acetylcholine (preganglionic neurons and parasympathetic terminals) and catecholamines (noradrenaline in sympathetic nerve terminals and adrenaline released from the adrenal glands). Interestingly enough the transmitters involved, their receptors, and post-receptor signaling undergo age-associated changes throughout the brain and the body. During senescence a shift of the cardiac ANS toward an increase in sympathetic activation has been observed. A better understanding of the underlying mechanisms is clinically pertinent because of the possible interconnection of age-dependent sympathetic nervous changes with cardiovascular disease development. This chapter specifically deals with the effects of aging on the molecular mechanisms implicated at central, ganglia, and synaptic (both pre- and postsynaptic) levels in the regulation of heart functioning. Since neurotrophins are involved in differentiation, synaptogenesis, and survival of ANS neurons, the consequences of age-related changes, specifically in NGF and BDNF expression, are also examined at cardiac level. Moreover, considering the importance of baroreceptor reflexes in the maintenance of the circulatory homeostasis, their alterations during senescence are also considered.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Esler MD, Turner AG, Kaye DM, et al. Aging effects on human sympathetic neuronal function. Am J Physiol. 1995;268:R278–85.
Esler M, Kaye D. Sympathetic nervous system activation in essential hypertension, cardiac failure and psychosomatic heart disease. J Cardiovasc Pharmacol. 2000;35 Suppl 4:S1–7.
Kenney MJ. Animal aging and regulation of sympathetic nerve discharge. J Appl Physiol (1985). 2010;109(4):951–8.
Barman SM. Brainstem control of cardiovascular function. In: Klemm WR, Vertes RP, editors. Brainstem mechanisms of behavior. New York: Wiley; 1990. p. 353–81.
Sun MK. Central neural organization and control of sympathetic nervous system in mammals. Prog Neurobiol. 1995;47(3):157–233.
Dampney RA, Horiuchi J, Tagawa T, et al. Medullary and supramedullary mechanisms regulating sympathetic vasomotor tone. Acta Physiol Scand. 2003;177(3):209–18.
Itoh H, Buñag RD. Aging reduces cardiovascular and sympathetic responses to NTS injections of serotonin in rats. Exp Gerontol. 1992;27(3):309–20.
Huangfu DH, Koshiya N, Guyenet PG. A5 noradrenergic unit activity and sympathetic nerve discharge in rats. Am J Physiol Regul Integr Comp Physiol. 1991;261:R393–402.
Van Huysse JW, Bealer SL. Central nervous system norepinephrine release, hypotension and hyperosmolality in conscious rats. Am J Physiol Regul Integr Comp Physiol. 1991;260:R1071–6.
Esler M, Hastings J, Lambert G, et al. The influence of aging on the human sympathetic nervous system and brain norepinephrine turnover. Am J Physiol Regul Integr Comp Physiol. 2002;282(3):R909–16.
Dickstein DL, Kabaso D, Rocher AB, et al. Changes in the structural complexity of the aged brain. Aging Cell. 2007;6:275–84.
Alkadhi K, Alzoubi K. Role of long-term potentiation of sympathetic ganglia (gLTP) in hypertension. Clin Exp Hypertens. 2007;29(5):267–86.
Partanen M, Waller SB, London ED, et al. Indices of neurotransmitter synthesis and release in aging sympathetic nervous system. Neurobiol Aging. 1985;6:227–32.
Schmidt RE. Age-related sympathetic ganglionic neuropathology: human pathology and animal models. Auton Neurosci. 2002;96(1):63–72.
Seals DR, Esler MD. Human ageing and the sympathoadrenal system. J Physiol. 2000;528(Pt 3):407–17.
Ziegler MG, Lake CR, Kopin IJ. Plasma noradrenaline increases with age. Nature. 1976;261:333–5.
Jones DH, Hamilton CA, Reid JL. Plasma noradrenaline, age, and blood pressure: a population study. Clin Sci Mol Med Suppl. 1978;4:73s–5.
Goldstein DS, Lake CF, Chernow B, et al. Age-dependence of hypertensive-normotensive differences in plasma norepinephrine. Hypertension. 1983;5:100–4.
Padovani A, Govoni S, Battaini F, et al. Alcohol impairs age-dependent adaptation of human lymphocyte beta-adrenergic receptors. Eur J Clin Invest. 1987;17(6):511–4.
Rubin PC, Scott PJ, McLean K, et al. Noradrenaline release and clearance in relation to age and blood pressure in man. Eur J Clin Invest. 1982;12:121–5.
Schwartz RS, Jaeger LF, Veith RC. The importance of body composition to the increase in plasma norepinephrine appearance rate in elderly men. J Gerontol. 1987;42:546–51.
Marker JC, Cryer PE, Clutter WE. Simplified measurement of norepinephrine kinetics: application to studies of aging and exercise training. Am J Physiol. 1994;267:E380–7.
Esler M, Skews H, Leonard P, et al. Age-dependence of noradrenaline kinetics in normal subjects. Clin Sci (Lond). 1981;60:217–9.
Morrow LA, Linares OA, Hill TJ, et al. Age differences in the plasma clearance mechanisms for epinephrine and norepinephrine in humans. J Clin Endocrinol Metab. 1987;65:508–11.
Esler M, Kaye D, Thompson J, et al. Effects of aging on epinephrine secretion and regional release of epinephrine from the human heart. J Clin Endocrinol Metab. 1995;80:435–42.
Daly RN, Goldberg PB, Roberts J. The effect of age on presynaptic alpha 2 adrenoceptor autoregulation of norepinephrine release. J Gerontol. 1989;44:B59–66.
Buchholz J, Duckles SP. Effect of age on prejunctional modulation of norepinephrine release. J Pharmacol Exp Ther. 1990;252:159–64.
Docherty JR. Cardiovascular responses in ageing: a review. Pharmacol Rev. 1990;42(2):103–25.
Aggarwal A, Esler MD, Socratous F, et al. Evidence for functional presynaptic alpha-2 adrenoceptors and their down-regulation in human heart failure. J Am Coll Cardiol. 2001;37:1246–51.
Molderings G, Likungu J, Zerkowski HR, et al. Presynaptic β2-adrenoceptors on the sympathetic nerve fibres of the human saphenous vein: no evidence for involvement in adrenaline-mediated positive feedback loop regulating noradrenergic transmission. Naunyn-Schmiedeberg’s Arch Pharmacol. 1988;337:408–14.
Starke K, Gothert M, Kilbinger H. Modulation of neurotransmitter release by presynaptic autoreceptors. Physiol Rev. 1989;69:864–989.
Docherty JR. Age-related changes in adrenergic neuroeffector transmission. Auton Neurosci. 2002;96(1):8–12.
Borton M, Docherty JR. The effects of ageing on neuronal uptake of noradrenaline in the rat. Naunyn Schmiedebergs Arch Pharmacol. 1989;340:139–43.
Li ST, Holmes C, Kopin IJ, et al. Aging-related changes in cardiac sympathetic function in humans, assessed by 6-18F-fluorodopamine PET scanning. J Nucl Med. 2003;44:1599–603.
Leenen FH, Coletta E, Fourney A, et al. Aging and cardiac responses to epinephrine in humans: role of neuronal uptake. Am J Physiol Heart Circ Physiol. 2005;288:H2498–503.
Klein C, Gerber JG, Gal J, et al. Beta-adrenergic receptors in the elderly are not less sensitive to timolol. Clin Pharmacol Ther. 1986;40(2):161–4.
Conway J, Wheeler R, Sannerstedt R. Sympathetic nervous activity during exercise in relation to age. Cardiovasc Res. 1971;5(4):577–81.
White M, Leenen FH. Aging and cardiovascular responsiveness to beta-agonist in humans: role of changes in beta-receptor responses versus baroreflex activity. Clin Pharmacol Ther. 1994;56:543–53.
Brodde OE, Leineweber K. Autonomic receptor systems in the failing and aging human heart: similarities and differences. Eur J Pharmacol. 2004;500(1–3):167–76.
Brodde OE, Zerkowski HR, Schranz D, et al. Age dependent changes in the beta-adrenoceptor–G-protein(s)–adenylyl cyclase system in human right atrium. J Cardiovasc Pharmacol. 1995;26:20–6.
Xiao RP, Tomhave ED, Wang DJ, et al. Age-associated reductions in cardiac beta1- and beta2-adrenergic responses without changes in inhibitory G proteins or receptor kinases. J Clin Invest. 1998;101(6):1273–82.
Kaye DM, Esler MD. Autonomic control of the aging heart. Neuromolecular Med. 2008;10(3):179–86.
Jose AD, Stitt F, Collison D. The effects of exercise and changes in body temperature on the intrinsic heart rate in man. Am Heart J. 1970;79(4):488–98.
Davies MJ. Pathology of the conducting system. In: Caird FL, Dall JLC, Kennedy RD, editors. Cardiology in old age. New York: Plenum; 1976. p. 57–9.
Masi CM, Hawkley LC, Rickett EM, et al. Respiratory sinus arrhythmia and diseases of aging: obesity, diabetes mellitus, and hypertension. Biol Psychol. 2007;74(2):212–23.
Brodde OE, Konschak U, Becker K, et al. Cardiac muscarinic receptors decrease with age. In vitro and in vivo studies. J Clin Invest. 1998;101(2):471–8.
Poller U, Nedelka G, Radke J, et al. Age-dependent changes in cardiac muscarinic receptor function in healthy volunteers. J Am Coll Cardiol. 1997;29(1):187–93.
Giessler C, Wangemann T, Zerkowski HR, et al. Age-dependent decrease in the negative inotropic effect of carbachol on isolated human right atrium. Eur J Pharmacol. 1998;357:199–202.
Liu HR, Zhao RR, Zhi JM, et al. Screening of serum autoantibodies to cardiac beta1-adrenoceptors and M2-muscarinic acetylcholine receptors in 408 subjects of varying ages. Autoimmunity. 1999;29:43–51.
Monahan KD. Effect of aging on baroreflex function in humans. Am J Physiol Regul Integr Comp Physiol. 2007;293(1):R3–12.
Laitinen T, Hartikainen J, Vanninen E, et al. Age and gender dependency of baroreflex sensitivity in healthy subjects. J Appl Physiol. 1998;84:576–83.
Monahan KD, Dinenno FA, Seals DR, et al. Age-associated changes in cardiovagal baroreflex sensitivity are related to central arterial compliance. Am J Physiol Heart Circ Physiol. 2001;281:H284–9.
Studinger P, Goldstein R, Taylor JA. Age- and fitness-related alterations in vascular sympathetic control. J Physiol. 2009;587(Pt 9):2049–57.
Monahan KD. A new answer to an old question: does ageing modify baroreflex control of vascular sympathetic outflow in humans? J Physiol. 2009;587(Pt 9):1857.
Lanni C, Stanga S, Racchi M, et al. The expanding universe of neurotrophic factors: therapeutic potential in aging and age-associated disorders. Curr Pharm Des. 2010;16(6):698–717.
Govoni S, Pascale A, Amadio M, et al. NGF and heart: is there a role in heart disease? Pharmacol Res. 2011;63(4):266–1277.
Mattson MP, Wan R. Neurotrophic factors in autonomic nervous system plasticity and dysfunction. Neuromolecular Med. 2008;10(3):157–68.
Hasan W, Smith PG. Nerve growth factor expression in parasympathetic neurons: regulation by sympathetic innervation. Eur J Neurosci. 2000;12:4391–7.
Causing CG, Gloster A, Aloyz R, et al. Synaptic innervation density is regulated by neuron-derived BDNF. Neuron. 1997;18:257–67.
Zhou X, Nai Q, Chen M, et al. Brain-derived neurotrophic factor and trkB signaling in parasympathetic neurons: relevance to regulating alpha7-containing nicotinic receptors and synaptic function. J Neurosci. 2004;24:4340–50.
Loewenthal N, Levy J, Schreiber R, et al. Nerve growth factor-tyrosine kinase A pathway is involved in thermoregulation and adaptation to stress: studies on patients with hereditary sensory and autonomic neuropathy type IV. Pediatr Res. 2005;57:587–90.
Wan R, Weigand LA, Bateman R, et al. Evidence that BDNF regulates heart rate by a mechanism involving increased brainstem parasympathetic neuron excitability. J Neurochem. 2014;129(4):573–80.
Wang H, Zhou XF. Injection of brain-derived neurotrophic factor in the rostral ventrolateral medulla increases arterial blood pressure in anaesthetized rats. Neuroscience. 2002;112:967–75.
Yang B, Slonimsky JD, Birren SJ. A rapid switch in sympathetic neurotransmitter release properties mediated by the p75 receptor. Nat Neurosci. 2002;5:539–45.
Zhou S, Chen LS, Miyauchi Y, et al. Mechanisms of cardiac nerve sprouting after myocardial infarction in dogs. Circ Res. 2004;95:76–83.
Cao JM, Chen LS, KenKnight BH, et al. Nerve sprouting and sudden cardiac death. Circ Res. 2000;86:816–21.
Hassankhani A, Steinhelper ME, Soonpaa MH, et al. Overexpression of NGF within the heart of transgenic mice causes hyperinnervation, cardiac enlargement, and hyperplasia of ectopic cells. Dev Biol. 1995;169:309–21.
Chen PS, Chen LS, Cao JM, et al. Sympathetic nerve sprouting, electrical remodeling and the mechanisms of sudden cardiac death. Cardiovasc Res. 2001;50:409–16.
Vracko R, Thorning D, Frederickson RG. Nerve fibers in human myocardial scars. Hum Pathol. 1991;22:138–46.
Cao JM, Fishbein MC, Han JB, et al. Relationship between regional cardiac hyperinnervation and ventricular arrhythmia. Circulation. 2000;101:1960–9.
Saygili E, Kluttig R, Rana OR, et al. Age-related regional differences in cardiac nerve growth factor expression. Age (Dordr). 2012;34(3):659–67.
Cai D, Holm JM, Duignan IJ, et al. BDNF-mediated enhancement of inflammation and injury in the aging heart. Physiol Genomics. 2006;24(3):191–7.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Pascale, A., Govoni, S. (2016). Cerebral Aging: Implications for the Heart Autonomic Nervous System Regulation. In: Gronda, E., Vanoli, E., Costea, A. (eds) Heart Failure Management: The Neural Pathways. Springer, Cham. https://doi.org/10.1007/978-3-319-24993-3_9
Download citation
DOI: https://doi.org/10.1007/978-3-319-24993-3_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-24991-9
Online ISBN: 978-3-319-24993-3
eBook Packages: MedicineMedicine (R0)